Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

A bitter pill to swallow: young people dislike tablets more than old

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.

Kemwell CEO says environmental efforts are worth the cost

Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a new COA guide issued by IPEC Americas.

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.

Is risk-based clinical trial monitoring too flexible for the regulators?

The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trade show CPhI last month according to expert Jan Ramakers.

Optimism is returning to the pharma fine chemicals sector, says analyst

CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.

Cobra Biologics talks recent fill finish acquisition and future growth plans

Catalent says making its technology available to industry will not affect its competitive edge.

Catalent says sharing with industry will not dull competetive edge

Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US.

Capsugel expands liquid fill capsule capabilities

Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow.

Bend Research hunting new partnerships to boost bioavailability offering

The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer.

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding.

New filtration tech boosts biomanufacturing yields, says Sartorius

Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor.

Submit good REMS proposals for FDA brownie points, says RAPS author

Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles.

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor.

Initial investment in REMS means big pay-put for pharma, says RAPS author

The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co.

The use of home visits in clinical trials could raise the chances of regulatory approval, according to <a href="http://ResearchNurses.co" rel="nofollow" target="_blank">ResearchNurses.co</a>.

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co.

Including home visits in clinical trial designs could be the key to patient retention, according to <a href="http://ResearchNurses.co" rel="nofollow" target="_blank">ResearchNurses.co</a>.

Home visits are the key to patient retention, says ResearchNurses.co

‘CROs: look at the entire portfolio, not just the individual project, when planning clinical studies,’ says DIA’s adaptive design scientific working group.

R&D and commercial work together to design trials, says DIA

Reduce changeover time on oral solid dose machinery by cleaning equipment offline, Fette Compacting urged drugsmakers at this year’s Interphex.

Fette's 'common sense' approach to boosting production

Outsourcing-Pharma Podcast

The best podcast episodes on non-current politics. Covering topics such as universal basic income, democracy, poverty & justice and more. For anyone interested in learning more about politics that affect that world, not just now, but in the longer term. Add episodes you're interested into your queue below!

Best Non-Current Politics Podcasts

The best philosophy podcast episodes. Asking questions about how to live a better life, what it means to be and do good, to the idea of God. This topic includes episodes that bring about important questions that everyone should be asking themselves. Add episodes you're interested into your queue below!